Table 2.
Percentage of patients with grade 2+ and grade 3+ paclitaxel/carboplatin-induced CIPN by CTCAE
| Glutathione (N=94) |
Placebo (N=91) |
Total (N=185) |
p-value | |
|---|---|---|---|---|
| Indicator: Grade 2+ CIPN | 0.451 | |||
| No | 58 (62%) | 61 (67%) | 119 (64%) | |
| Yes | 36 (38%) | 30 (33%) | 66 (36%) | |
| Indicator: Grade 3+ CIPN | 0.771 | |||
| No | 89 (95%) | 87 (96%) | 176 (95%) | |
| Yes | 5 (5%) | 4 (4%) | 9 (5%) |
Chi-Square test